<SEC-DOCUMENT>0001079973-25-001728.txt : 20251114
<SEC-HEADER>0001079973-25-001728.hdr.sgml : 20251114
<ACCEPTANCE-DATETIME>20251114081414
ACCESSION NUMBER:		0001079973-25-001728
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251114
DATE AS OF CHANGE:		20251114

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BNB PLUS CORP.
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-TESTING LABORATORIES [8734]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-78682
		FILM NUMBER:		251481379

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	APPLIED DNA SCIENCES INC
		DATE OF NAME CHANGE:	20021218

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			S.H.N. Financial Investments Ltd.
		CENTRAL INDEX KEY:			0001890802
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		3 ARIK EINSTEIN ST.
		STREET 2:		B ENTRANCE
		CITY:			HERZLIYA
		STATE:			L3
		ZIP:			4610301
		BUSINESS PHONE:		927(0)779800501

	MAIL ADDRESS:	
		STREET 1:		3 ARIK EINSTEIN ST.
		STREET 2:		B ENTRANCE
		CITY:			HERZLIYA
		STATE:			L3
		ZIP:			4610301
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001079973-24-000852</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: S.H.N. Financial Investments Ltd. -->
          <cik>0001890802</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>11/14/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0000744452</issuerCik>
        <issuerName>Applied DNA Sciences Inc.</issuerName>
        <issuerCusip>03815U607</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>50 Health Sciences Drive</com:street1>
          <com:city>Stony Brook</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>11790</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>S.H.N. Financial Investments Ltd.</reportingPersonName>
      <citizenshipOrOrganization>L3</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>155586.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>155586.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>155586.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>3.4</classPercent>
      <typeOfReportingPerson>FI</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Applied DNA Sciences Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>50 Health Sciences Drive, Stony Brook, NY 11790</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>S.H.N. Financial Investments Ltd.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Herzliya Hills
Arik Einstein 3, Israel, 4610301</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Israel</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>155,586

This amendment refers to a Schedule 13G filed with the Securities and Exchange Commission on June 7, 2024, covering 1,013,807 Common Shares purchased on May 28, 2024. The amounts in Row (5), (7) and (9) represent 152,669 Series A Warrants and 2,917 Series C Warrants, each to purchase shares of Common Stock of the Issuer. The percentage set forth on Row (11) of the cover page for the reporting person is based on 4,354,782 shares of Common Stock outstanding as of October 31, 2025, based on the Issuer's Preliminary Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on October 30, 2025.

Nir Shamir is the Chief Executive Officer of the Reporting Person. As such, Mr. Shamir may be deemed to beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the securities described herein. To the extent Mr. Shamir is deemed to beneficially own such securities, Mr. Shamir disclaims beneficial ownership of these securities for all other purposes.</amountBeneficiallyOwned>
        <classPercent>3.4%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>155,586</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>155,586</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>N</notApplicableFlag>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>S.H.N. Financial Investments Ltd.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Nir Shamir</signature>
        <title>Nir Shamir, Chief Executive Officer</title>
        <date>11/14/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
